Shandong Weigao Group Medical Polymer Co (1066)
Shandong Weigao Group Medical Polymer Co., Ltd. engages in the research and development, production, and sale of single-use medical devices. It operates through three segments: Single-Use Medical Products, Orthopaedic Products and Blood Purification Products. The Single-Use Medical Products segment involves the production and sale of single use consumables such as infusion sets, syringes, blood transfusion sets, and blood bags. The Orthopaedic Products segment engages in production and sale of orthopaedic products such as platelet segregator, blood plasma catheter and blood cell segregator. The Blood Purification Products segment covers the production and sale of blood purification products and related medical equipment. The company was founded in 1988 and is headquartered in Weihai, China.
|Market Price at 20-11-2017||$5.70|
|Price to Earnings Ratio||17.95|
|Market Capitalisation||$25,777.28 (million)|
|Return on Equity (ROE)||9.76%|